Back to Trasylol®

What is Trasylol® (Aprotinin)?

Trasylol® (aprotinin injection) is a medication given before heart surgery (typically coronary artery bypass grafting surgery) to control bleeding and the need for blood transfusions. Trasylol® is manufactured from tissue taken from cows.

What are the risks associated with Trasylol®?

The following are the potential health risks and side effects of Trasylol®:

• Serious Allergic Reaction (Anaphylactic Reaction)
• Kidney Damage
• Kidney Failure
• Stroke
• Heart Attack
• Death

What should I do if I need a coronary artery bypass graft surgery?

If you are scheduled to have a coronary artery bypass graft surgery (CABG) or any other heart surgery, ask your surgeon if they intend to use Trasylol®. Tell your doctor if you:

• Have had Trasylol® (aprotinin) in the past
• Have had heart surgery
• Have kidney disease
• Are allergic to any medicines
• Are taking prescribed or over-the-counter medications
• Are pregnant

FDA Alert - February 2006

A new study suggests that Trasylol® may increase the chance for serious side effects including kidney failure, stroke, heart attack, and death in some people.

Another new study suggests that Trasylol® may increase the chance for kidney failure.

The Food and Drug Administration is currently analyzing the results from these new studies and will provide more information as it becomes known.

If you or someone you know has undergone a coronary artery bypass grafting surgery and subsequently developed the onset of kidney failure, please use the form on the left to contact our law firm.

Reference:

"Patient Information Sheet Aprotinin (marketed as Trasylol)," FDA, February 2006.